Evaluation of cannabidiol nanoparticles and nanoemulsion biodistribution in the central nervous system after intrathecal administration for the treatment of pain

doi: 10.1016/j.nano.2023.102664.

Online ahead of print.

Affiliations

PMID: 36813014
DOI: 10.1016/j.nano.2023.102664

Abstract

We investigated how the biodistribution of cannabidiol (CBD) within the central nervous system (CNS) is influenced by two different formulations, an oil-in-water (O/W) nanoemulsion and polymer-coated nanoparticles (PCNPs). We observed that both CBD formulations administered were preferentially retained in the spinal cord, with high concentrations reaching the brain within 10 mins of administration. The CBD nanoemulsion reached C_max in the brain at 210 ng/g within 120 mins (T_max), whereas the CBD PCNPs had a C_max of 94 ng/g at 30 mins (T_max), indicating that rapid brain delivery can be achieved through the use of PCNPs. Moreover, the AUC_{0-4 h} of CBD in the brain was increased 3.7-fold through the delivery of the nanoemulsion as opposed to the PCNPs, indicating higher retention of CBD at this site. Both formulations exhibited immediate anti-nociceptive effects in comparison to the respective blank formulations.

Keywords: Cannabidiol, Drug-delivery, Intrathecal, Nanoemulsion, Polymer-coated nanoparticles

Similar articles

Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol.

Kok LY, Bannigan P, Sanaee F, Evans JC, Dunne M, Regenold M, Ahmed L, Dubins D, Allen C.Eur J Pharm Sci. 2022 Jan 1;168:106058. doi: 10.1016/j.ejps.2021.106058. Epub 2021 Nov 8.PMID: 34763088
Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization,in vitroandin vivoevaluation.

Ahmed B, Rizwanullah M, Mir SR, Akhtar MS, Amin S.Biomed Mater. 2022 Sep 28;17(6). doi: 10.1088/1748-605X/ac9267.PMID: 36108625
Development of a Novel Nano-emulsion Formulation to Improve Intestinal Absorption of Cannabidiol.

Nakano Y, Tajima M, Sugiyama E, Sato VH, Sato H.Med Cannabis Cannabinoids. 2019 Apr 4;2(1):35-42. doi: 10.1159/000497361. eCollection 2019 Sep.PMID: 34676332 Free PMC article.
Current trends on cannabidiol delivery systems: where are we and where are we going?

Ramalho ÍMM, Pereira DT, Galvão GBL, Freire DT, Amaral-Machado L, Alencar ÉDN, Egito ESTD.Expert Opin Drug Deliv. 2021 Nov;18(11):1577-1587. doi: 10.1080/17425247.2021.1952978. Epub 2021 Jul 19.PMID: 34253133 Review.
Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities.

Grifoni L, Vanti G, Donato R, Sacco C, Bilia AR.Molecules. 2022 Sep 17;27(18):6070. doi: 10.3390/molecules27186070.PMID: 36144803 Free PMC article. Review.